Skip to main content
Log in

Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Ataxia telangiectasia mutated (ATM) is a key gene in DNA double-strand break (DSB), and therefore, most of its disabling genetic alterations play an important initiative role in many types of cancer. However, the exact role of ATM gene and its epigenetic alterations, especially promoter methylation in different grades of brain tumors, remains elusive. The current study was conducted to query possible correlations among methylation statue of ATM gene, ATM/ retinoblastoma (RB) protein expression, D1853N ATM polymorphism, telomere length (TL), and clinicopathological characteristics of various types of brain tumors. Isolated DNA from 30 fresh tissues was extracted from different types of brain tumors and two brain tissues from deceased normal healthy individuals. DNAs were treated with bisulfate sodium using DNA modification kit (Qiagen). Methylation-specific polymerase chain reaction (MSP-PCR) was implicated to determine the methylation status of treated DNA templates confirmed by promoter sequencing. Besides, the ATM and RB protein levels were determined by immunofluorescence (IF) assay using monoclonal mouse antihuman against ATM, P53, and RB proteins. To achieve an interactive correlation, the methylation data were statistically analyzed by considering TL and D1853N ATM polymorphism. More than 73 % of the brain tumors were methylated in ATM gene promoter. There was strong correlation between ATM promoter methylation and its protein expression (p < 0.001). As a triangle, meaningful correlation was also found between methylated ATM promoter and ATM protein expression with D1853N ATM polymorphism (p = 0.01). ATM protein expression was not in line with RB protein expression while it was found to be significantly correlated with ATM promoter methylation (p = 0.01). There was significant correlation between TL neither with ATM promoter methylation nor with ATM protein expression nor with D1853N polymorphism. However, TL has shown strong correlation with patient’s age and tumor grade (p = 0.01). Given the important role of cell cycle checkpoint proteins as well as RB and ATM in TL and cancer evolution, further assessment is warranted to shed more light on the pathway linking the telomere instability to tumor progression. High ATM methylation rate in brain tumor patients could open a new avenue toward early screening and cancer therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N (2005) ATM signaling and genomic stability in response to DNA damage. Mutat Res 569:123–132

    Article  CAS  PubMed  Google Scholar 

  2. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP (2006) ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8:37–45

    Article  CAS  PubMed  Google Scholar 

  3. Oliver AW, Knapp S, Pearl LH (2007) Activation segment exchange: a common mechanism of kinase autophosphorylation? Trends Biochem Sci 32:351–356

    Article  CAS  PubMed  Google Scholar 

  4. Berkovich E, Ginsberg D (2003) ATM is a target for positive regulation by E2F-1. Oncogene 22:161–167

    Article  CAS  PubMed  Google Scholar 

  5. Lin WC, Lin FT, Nevins JR (2001) Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15:1833–1844

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633–637

    Article  CAS  PubMed  Google Scholar 

  7. Liang Y, Lin SY, Brunicardi FC, Goss J, Li K (2009) DNA damage response pathways in tumor suppression and cancer treatment. World J Surg 33:661–666

    Article  PubMed  Google Scholar 

  8. Ye C, Cai Q, Dai Q, Shu XO, Shin A, Gao YT, Zheng W (2007) Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival. Cancer 109:1729–1735

    Article  PubMed  Google Scholar 

  9. Chiu YT, Liu J, Tang K, Wong YC, Khanna KK, Ling MT (2012) Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells. PLoS One 7:e51108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ye J, Qi Y, Wang W, Sun F, Wei Q, Su T, Zhou W, Jiang Y, Yuan W, Cai J, Cui B, Ning G (2012) Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas. Endocrine 41:479–486

    Article  CAS  PubMed  Google Scholar 

  11. Kim JW, Im SA, Kim MA, Cho HJ, Lee DW, Lee KH, Kim TY, Han SW, Oh DY, Lee HJ, Yang HK, Kim WH, Bang YJ (2013) Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker. Int J Cancer 134:72–80

    Article  CAS  PubMed  Google Scholar 

  12. Wu CW, Dong YJ, Liang QY, He XQ, Ng SS, Chan FK, Sung JJ, Yu J (2013) MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. PLoS One 8:e57036

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Morgan WF, Corcoran J, Hartmann A, Kaplan MI, Limoli CL, Ponnaiya B (1998) DNA double-strand breaks, chromosomal rearrangements, and genomic instability. Mutat Res 404:125–128

    Article  CAS  PubMed  Google Scholar 

  14. Sinha S, Ghildiyal R, Mehta VS, Sen E (2013) ATM-NFkappaB axis-driven TIGAR regulates sensitivity of glioma cells to radiomimetics in the presence of TNFalpha. Cell Death Dis 4:e615

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Kheirollahi M, Mehr-Azin M, Kamalian N, Mehdipour P (2011) Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors. Med Oncol 28:7–14

    Article  CAS  PubMed  Google Scholar 

  16. Liberzon E, Avigada S, Cohen IJ, Yaniv I, Michovitz SH, Zaizov R (2003) ATM gene mutations are not involved in medulloblastoma in children. Cytogenet 146:167–169

    Article  CAS  Google Scholar 

  17. Mehdipour P, Mahdavi M, Mohammadi-Asl J, Atri M (2011) Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer. Med Oncol 28:733–737

    Article  CAS  PubMed  Google Scholar 

  18. Mehdipour P, Habibi L, Mohammadi-Asl J, Kamalian N, Mehr Azin M (2008) Three-hit hypothesis in astrocytoma: tracing the polymorphism D1853N in ATM gene through a pedigree of the proband affected with primary brain tumor. J Cancer Res Clin Oncol 134:1173–1180

    Article  CAS  PubMed  Google Scholar 

  19. Muraki K, Han L, Miller D, Murnane JP (2013) The role of ATM in the deficiency in nonhomologous end-joining near telomeres in a human cancer cell line. PLoS Genet 9:e1003386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kim WJ, Vo QN, Shrivastav M, Lataxes TA, Brown KD (2002) Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line. Oncogene 21:3864–3871

    Article  CAS  PubMed  Google Scholar 

  21. Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, Hanna E, Brown KD, Fan CY (2004) Ataxia-telangiectasiamutated (ATM) gene in head and neck squamous cell carcinoma: promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev 13:150–156

    Article  CAS  PubMed  Google Scholar 

  22. Vo QN, Kim WJ, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD (2004) The ATM gene is a target for epigenetic silencing in locally advanced breast cancer. Oncogene 23:9432–9437

    Article  CAS  PubMed  Google Scholar 

  23. Roy K, Wang L, Makrigiorgos GM, Price BD (2006) Methylation of the ATM promoter in glioma cells alters ionizing radiation sensitivity. Biochem Biophys Res Commun 344:821–826

    Article  CAS  PubMed  Google Scholar 

  24. Safar AM, Spencer H, Su X, Cooney CA, Shwaiki A, Fan CY (2007) Promoter hypermethylation for molecular nodal staging in non-small cell lung cancer. Arch Pathol Lab Med 131:936–941

    CAS  PubMed  Google Scholar 

  25. Flanagan JM, Wilhelm-Benartzi CS, Metcalf M, Kaye SB, Brown R (2013) Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients. Ann Oncol 24:2813–2818

    Article  CAS  PubMed  Google Scholar 

  26. Bhattacharya N, Mukherjee N, Singh R, Sinha S, Alam N, Roy A, Roychoudhury S, Panda C (2012) Frequent alterations of MCPH1 and ATM are associated with primary breast carcinoma: clinical and prognostic implications. Ann Surg Oncol:1–9

  27. Kheirollahi M, Mehrazin M, Kamalian N, Mehdipour P (2010) Alterations of telomere length in human brain tumors. Med Oncol 28:864–870

    Article  PubMed  Google Scholar 

  28. Kanoh J, Francesconi S, Collura A, Schramke V, Ishikawa F, Baldacci G, Geli V (2003) The fission yeast spSet1p is a histone H3-K4 methyltransferase that functions in telomere maintenance and DNA repair in an ATM kinase Rad3-dependent pathway. J Mol Biol 326:1081–1094

    Article  CAS  PubMed  Google Scholar 

  29. Treilleux I, Chapot B, Goddard S, Pisani P, Angele S, Hall J (2007) The molecular causes of low ATM protein expression in breast carcinoma; promoter methylation and levels of the catalytic subunit of DNA-dependent protein kinase. Histopathology 51:63–69

    Article  CAS  PubMed  Google Scholar 

  30. Tapia T, Sanchez A, Vallejos M, Alvarez C, Moraga M, Smalley S, Camus M, Alvarez M, Carvallo P (2008) ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences? Breast Cancer Res Treat 107:281–288

    Article  CAS  PubMed  Google Scholar 

  31. Meier M, den Boer ML, Hall AG, Irving JA, Passier M, Minto L, van Wering ER, Janka-Schaub GE, Pieters R (2005) Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia. Leukemia 19:1887–1895

    Article  CAS  PubMed  Google Scholar 

  32. Kim S, Parks CG, Xu Z, Carswell G, DeRoo LA, Sandler DP, Taylor JA (2012) Association between genetic variants in DNA and histone methylation and telomere length. PLoS One 7:e40504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Silva E, Tiong S, Pedersen M, Homola E, Royou A, Fasulo B, Siriaco G, Campbell SD (2004) ATM is required for telomere maintenance and chromosome stability during Drosophila development. Curr Biol 14:1341–1347

    Article  CAS  PubMed  Google Scholar 

  34. Gonzalo S, Garcia-Cao M, Fraga MF, Schotta G, Peters AH, Cotter SE, Eguia R, Dean DC, Esteller M, Jenuwein T, Blasco MA (2005) Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol 7:420–428

    Article  CAS  PubMed  Google Scholar 

  35. Garcia-Cao M, Gonzalo S, Dean D, Blasco MA (2002) A role for the Rb family of proteins in controlling telomere length. Nat Genet 32:415–419

    Article  CAS  PubMed  Google Scholar 

  36. Blackburn E (2001) Switching and signaling at the telomere. Cell 106:661–673

    Article  CAS  PubMed  Google Scholar 

  37. Artandi SE, DePinho RA (2010) Telomeres and telomerase in cancer. Carcinogenesis 31:9–18

    Article  CAS  PubMed  Google Scholar 

  38. Lee S, Donehower LA, Herron AJ, Moore DD, Fu L (2010) Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS 10

Download references

Acknowledgments

This is to acknowledge the surgery and nursery teams in Shariati hospital and also the patients for their support.

Conflict of Interest

There is no commercial/financial conflict of interest among all of the authors of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Mehdipour.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mehdipour, P., Karami, F., Javan, F. et al. Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory. Mol Neurobiol 52, 293–302 (2015). https://doi.org/10.1007/s12035-014-8864-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-014-8864-9

Keywords

Navigation